From
StayCurrentMD
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
With Dr. Sophia Schermerhorn
Chapter 1 of 1 · Evidence & Research
Quality of Life Outcomes in Hepatoblastoma Treatment
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
BOB Ped Surg 2023 - Andrew Fleming, AAP - Presentation
Published Feb 2023
Video
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
1 min · Published Jan 2026
Video
Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival
Published Jun 2023
Video
Hepatoblastoma with Dr. Greg Tiao
CCHMC Pediatric Surgery · Published Mar 2022
Video
Social Determinants of Health Influence on Survival in Wilms Tumor, Neuroblastoma, and Hepatoblastoma
1 min · Published Jan 2026
Video
Hepatoblastoma: Update Course 2014
24 min · Published Nov 2018
Video
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
1 min · Published Apr 2026
Video
Pediatric Obesity Is a Disease: Treatment, Medications, Surgery & Equity in Care with Dr. Justin Ryder
Lurie Children's Hospital · 6 min · Published Mar 2026
Podcast
Journal of Pediatric Article Review: June 2023, AAP Issue
13 min · Published Sep 2023
Podcast
Journal of Pediatric Surgery Article Review: June 2022, AAP Issue
15 min · Published Sep 2022
Podcast
Hepatoblastoma
54 min · Published Nov 2017
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
1 min · Published Apr 2026
Video
Clinical & Research Update: Pediatric Liver Tumors - A Case-Based Discussion with Drs. Katherine Somers & Alex Bondoc
69 min · Published Apr 2026
Video
Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?
1 min · Published Feb 2026
Video
Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma
1 min · Published Feb 2026
Video
Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma
1 min · Published Jan 2026
Video
Pediatric Surgical Oncology Research Collaborative (PSORC): Studying Rare Pediatric Tumors
56 s · Published May 2026
Video
Update Course Rewind 2025: Hirschsprung + ARM: Rare but Real
1 min · Published May 2026
Video
Pooling Patients to Study Rare Pediatric Tumors: An Introduction to PSORC
56 s · Published May 2026
Video
The fetal frontier: A review of current and emerging fetal therapies for genetic diseases
44 s · Published May 2026
Video
Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle
46 s · Published May 2026
Video
Early Tricuspid Valve Surgery for Heart Failure in Congenital Heart Disease
46 s · Published May 2026
What the experts said
Survival for hepatoblastoma continues to improve.
Long-term quality of life is becoming a more important outcome as hepatoblastoma survival improves.
This is a single institution cross-sectional study using validated pediatric quality of life surveys to evaluate long-term survivors of hepatoblastoma.
Overall quality of life outcomes were similar between liver transplant and resection groups for hepatoblastoma.
There was no significant difference in emotional, social, physical, or school functioning outcomes between transplant and resection groups.
Patients who underwent resection had lower overall procedure anxiety scores than transplant patients.
The finding of lower procedural anxiety in resection patients was mirrored in the parents' surveys.
Long-term quality of life outcomes appear comparable between patients who undergo resection and liver transplantation for hepatoblastoma.
Surgical strategy for hepatoblastoma can be focused on oncologic control given comparable quality of life outcomes.